Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,370 | 48 | 99.1% |
| Education | $12.16 | 1 | 0.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $569.62 | 8 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $303.09 | 24 | $0 (2022) |
| ABBVIE INC. | $229.75 | 6 | $0 (2023) |
| Phathom Pharmaceuticals, Inc. | $124.74 | 1 | $0 (2024) |
| Sumitomo Pharma America, Inc. | $54.79 | 5 | $0 (2023) |
| Supernus Pharmaceuticals, Inc. | $51.41 | 2 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $20.17 | 1 | $0 (2022) |
| Novo Nordisk Inc | $16.18 | 1 | $0 (2022) |
| IMPEL PHARMACEUTICALS INC. | $12.16 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $538.04 | 5 | AstraZeneca Pharmaceuticals LP ($376.22) |
| 2023 | $179.78 | 6 | ABBVIE INC. ($124.99) |
| 2022 | $395.33 | 30 | Sunovion Pharmaceuticals Inc. ($290.32) |
| 2021 | $268.76 | 8 | AstraZeneca Pharmaceuticals LP ($163.51) |
All Payment Transactions
49 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/05/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $126.22 | General |
| Category: Respiratory | ||||||
| 03/14/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 02/20/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $124.74 | General |
| Category: GASTROENTEROLOGY | ||||||
| 01/31/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Respiratory | ||||||
| 01/18/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $37.08 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 03/10/2023 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $10.16 | General |
| Category: UROLOGY | ||||||
| 03/09/2023 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $14.34 | General |
| Category: UROLOGY | ||||||
| 02/10/2023 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $13.68 | General |
| Category: UROLOGY | ||||||
| 02/07/2023 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $4.09 | General |
| Category: UROLOGY | ||||||
| 02/01/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: NEUROSCIENCE | ||||||
| 01/10/2023 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $12.52 | General |
| Category: UROLOGY | ||||||
| 11/28/2022 | Supernus Pharmaceuticals, Inc. | QELBREE (Drug) | Food and Beverage | Cash or cash equivalent | $14.33 | General |
| Category: PSYCHOLOGY | ||||||
| 11/23/2022 | Sunovion Pharmaceuticals Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $9.03 | General |
| Category: UROLOGY | ||||||
| 11/16/2022 | Sunovion Pharmaceuticals Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $15.89 | General |
| Category: UROLOGY | ||||||
| 11/10/2022 | Sunovion Pharmaceuticals Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $18.49 | General |
| Category: UROLOGY | ||||||
| 10/19/2022 | Sunovion Pharmaceuticals Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $15.44 | General |
| Category: UROLOGY | ||||||
| 10/13/2022 | Sunovion Pharmaceuticals Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $5.08 | General |
| Category: UROLOGY | ||||||
| 09/08/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $16.18 | General |
| Category: Diabetes | ||||||
| 08/30/2022 | Sunovion Pharmaceuticals Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $14.72 | General |
| Category: UROLOGY | ||||||
| 08/25/2022 | SANOFI-AVENTIS U.S. LLC | TOUJEO (Biological) | Food and Beverage | In-kind items and services | $20.17 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 08/23/2022 | Sunovion Pharmaceuticals Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $13.47 | General |
| Category: UROLOGY | ||||||
| 08/10/2022 | Sunovion Pharmaceuticals Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $12.64 | General |
| Category: UROLOGY | ||||||
| 08/08/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $12.28 | General |
| Category: NEUROSCIENCE | ||||||
| 07/19/2022 | Sunovion Pharmaceuticals Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $5.48 | General |
| Category: UROLOGY | ||||||
| 07/13/2022 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $14.41 | General |
| Category: Respiratory | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 18 | 1,300 | 2,155 | $363,231 | $91,301 |
| 2022 | 21 | 1,478 | 3,214 | $423,030 | $106,201 |
| 2021 | 17 | 1,211 | 1,856 | $294,738 | $71,236 |
| 2020 | 22 | 1,347 | 1,892 | $273,876 | $55,139 |
All Medicare Procedures & Services
78 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 230 | 463 | $141,583 | $31,189 | 22.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 186 | 325 | $67,368 | $15,604 | 23.2% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 35 | 35 | $37,625 | $9,599 | 25.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 86 | 86 | $28,343 | $8,932 | 31.5% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 84 | 84 | $21,730 | $5,823 | 26.8% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 281 | 642 | $10,411 | $5,377 | 51.6% |
| 87636 | Detection test by multiplex amplified probe technique for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (covid-19) and influenza virus types a and b | Office | 2023 | 21 | 22 | $9,480 | $3,075 | 32.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 91 | 91 | $8,204 | $2,605 | 31.8% |
| 91320 | Sarscv2 vac 30mcg trs-suc im | Office | 2023 | 19 | 19 | $7,543 | $2,441 | 32.4% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 17 | 17 | $8,296 | $2,258 | 27.2% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 34 | 34 | $3,074 | $973.42 | 31.7% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 57 | 99 | $7,249 | $932.96 | 12.9% |
| 90480 | Admn sarscov2 vacc 1 dose | Office | 2023 | 19 | 19 | $1,501 | $725.23 | 48.3% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 16 | 60 | $4,200 | $481.13 | 11.5% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 27 | 28 | $2,365 | $475.39 | 20.1% |
| 73030 | X-ray of shoulder, minimum of 2 views | Office | 2023 | 13 | 14 | $1,360 | $328.95 | 24.2% |
| 80305 | Testing for presence of drug, read by direct observation | Office | 2023 | 22 | 22 | $990.00 | $271.70 | 27.4% |
| 81003 | Automated urinalysis test | Office | 2023 | 62 | 95 | $1,909 | $209.00 | 10.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 238 | 437 | $133,285 | $28,654 | 21.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 229 | 418 | $86,526 | $20,235 | 23.4% |
| J0897 | Injection, denosumab, 1 mg | Office | 2022 | 12 | 900 | $58,500 | $15,246 | 26.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 92 | 92 | $30,268 | $9,722 | 32.1% |
| 87636 | Detection test by multiplex amplified probe technique for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (covid-19) and influenza virus types a and b | Office | 2022 | 39 | 47 | $20,116 | $6,468 | 32.2% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 94 | 94 | $21,560 | $6,361 | 29.5% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2022 | 15 | 15 | $14,025 | $4,171 | 29.7% |
About April Stewart, APN
April Stewart, APN is a Registered Nurse healthcare provider based in Clarksville, Indiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/20/2006. The National Provider Identifier (NPI) number assigned to this provider is 1275598294.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, April Stewart, APN has received a total of $1,382 in payments from pharmaceutical and medical device companies, with $538.04 received in 2024. These payments were reported across 49 transactions from 9 companies. The most common payment nature is "Food and Beverage" ($1,370).
As a Medicare-enrolled provider, Stewart has provided services to 5,336 Medicare beneficiaries, totaling 9,117 services with total Medicare billing of $323,877. Data is available for 4 years (2020–2023), covering 78 distinct procedure/service records.
Practice Information
- Specialty Registered Nurse
- Other Specialties Nurse Practitioner
- Location Clarksville, IN
- Active Since 04/20/2006
- Last Updated 10/05/2022
- Taxonomy Code 163W00000X
- Entity Type Individual
- NPI Number 1275598294
Products in Payments
- GEMTESA (Drug) $335.30
- AIRSUPRA (Drug) $251.22
- FARXIGA (Drug) $238.75
- VRAYLAR (Drug) $217.47
- VOQUEZNA (Drug) $124.74
- BREZTRI (Drug) $79.65
- Qelbree (Drug) $37.08
- APTIOM (Drug) $22.58
- TOUJEO (Biological) $20.17
- Rybelsus (Drug) $16.18
- QELBREE (Drug) $14.33
- QULIPTA (Drug) $12.28
- Trudhesa (Drug) $12.16
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Registered Nurse Doctors in Clarksville
Elizabeth Anderson, Rn, RN
Registered Nurse — Payments: $4,198
Tommy Sawyer, Fnp-Bc, FNP-BC
Registered Nurse — Payments: $4,075
Jewell Kaylor, Aprn, APRN
Registered Nurse — Payments: $3,076
Sarah Morris, Aprn, APRN
Registered Nurse — Payments: $2,064
Dr. Margarita Barlow, Dnp,Anp-Bc, Pmhnp-Bc, DNP,ANP-BC, PMHNP-BC
Registered Nurse — Payments: $994.54
Kristen Brunettin, Np, NP
Registered Nurse — Payments: $700.63